Other work8,24 reported a correlation of APRI and FIB-4 with fibrosis stage in HBeAg-negative patients with chronic hepatitis B and ALT ≤2 (upper normal limit) as well as in patients with chronic hepatitis B and non-alcoholic fatty liver disease. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.